Related Experiment Video
Updated: Sep 24, 2025

Development of Metarhizium anisopliae as a Mycoinsecticide: From Isolation to Field Performance
Published on: July 30, 2017
Mucormycosis in India: Pathophysiology and Perspectives on Treatment and Management
Utsav Gupta1, Deepika Paliwal1, Samridhi Rawat1
1Department of Pharmacy, School of Medical & Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India.
Abstract:
Mucormycosis, also known as "black fungus," is a potentially fatal disorder that causes blurred or double vision, chest pain, and breathing problems. The introduction of novel risk factors and causative agents, as well as the problems with controlling the disease, are all significant problems with mucormycosis in India. It is most common among COVID-19 patients. Mucormycosis is an invasive fungal disease that primarily affects immunosuppressant patients, mainly caused by mold fungi of the genus mucor, rhizopus, rhizomucor, and absidia, which are in the zygomycetes class and the Mucorales order. The most common risk factor is diabetes mellitus, followed by haematological malignancy and solid-organ transplantation. Reversal of underlying predisposing factors, surgical debridement of infected tissues, and proper antifungal therapy are all required for the treatment of mucormycosis. In this review, the epidemiology, pathogenesis, and symptoms of black fungus and its association with covid-19, treatment, and diagnosis are discussed.
Insights
Mucormycosis, or black fungus, is a dangerous infection affecting immunocompromised individuals, particularly those with diabetes. This review covers its epidemiology, pathogenesis, symptoms, and treatment, especially in COVID-19 patients.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Public Health
Background:
- Mucormycosis, known as "black fungus," is a severe, potentially fatal invasive fungal infection.
- It disproportionately affects immunocompromised patients, with a notable increase among COVID-19 survivors.
- Key risk factors include diabetes mellitus, hematological malignancy, and solid-organ transplantation.
Purpose of the Study:
- To review the epidemiology, pathogenesis, and clinical manifestations of mucormycosis.
- To discuss the association between mucormycosis and COVID-19.
- To outline current treatment and diagnostic strategies for black fungus infections.
Main Methods:
- This study is a comprehensive literature review.
- It synthesizes information on the causative agents, risk factors, and clinical presentation of mucormycosis.
- The review examines diagnostic approaches and therapeutic interventions.
Main Results:
- Mucormycosis is caused by fungi in the order Mucorales, commonly affecting patients with uncontrolled diabetes.
- Symptoms include blurred vision, chest pain, and respiratory distress.
- Effective management requires addressing predisposing factors, surgical debridement, and antifungal therapy.
Conclusions:
- Mucormycosis presents significant challenges in India due to emerging risk factors and treatment difficulties.
- Early diagnosis and multidisciplinary management are crucial for improving patient outcomes.
- Understanding the interplay between COVID-19 and mucormycosis is vital for public health strategies.
Related Concept Videos
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Cystic Fibrosis: Management
Sinus disease and chronic...
Endocarditis III: Medical Management

